Embark Delta Inc. Completes Additional Shipment to Province of Ontario

Toronto, Ontario--(Newsfile Corp. - April 19, 2021) -  Embark Delta Inc., a wholly owned subsidiary of Embark Health Inc. ("Embark" or the "Company") is pleased to announce the Company has successfully completed its product shipment of The Hazel Co. ("Hazel") Hash Sticks to the Province of Ontario through the Ontario Cannabis Store ("OCS"), which is the wholesaler and online retailer for recreational cannabis in Ontario.

"We are thrilled to continue to provide Ontario with our quality solventless concentrate products," said Dr. Luc C. Duchesne, CEO. "Embark is excited to deliver the Hazel Hash Stick to Ontario consumers and delighted to see that the OCS included the Hazel Hash Sticks in the top five list of new products to watch for at the OCS in their latest blogpost."

Cannot view this image? Visit: https://orders.newsfilecorp.com/files/7351/80809_67b0dd0e447058c6_001.jpg

To view an enhanced version of this graphic, please visit:

The hash stick is the signature product under Embark's Hazel brand and line-up of 2.0 solventless concentrates following The Hank Co. ("Hank") which was launched in Q1 2021. The Hazel Hash Sticks, launching in both Ontario and Saskatchewan, are a unique solventless concentrate for discerning cannabis connoisseurs who wish to expand their "go-to" options for concentrates. The Hazel Hash Stick is a solventless concentrate in a pre-roll form, hand-crafted into a 1-gram hollow tube. The hand-crafted hash stick comes without paper or filter; it can be enjoyed as is, without the use of additional specialized tools such as dab rigs or pens.

Make sure to follow Embark Health Inc. on LinkedIn, Facebook, and Instagram to keep up with latest news. Follow The Hazel Co. on Instagram and Facebook, and The Hank Co. on Instagram and Facebook.

About Embark Health Inc.

Embark Health Inc. is a leader in solventless cannabis extraction, with a focus on the formulation and production of advanced 2.0 products for the B2B, medical and adult-use markets. Embark continues to be at the forefront of production of concentrate products including bubble hash, traditional pressed hash, rosin, and dry sift. With the acquisition of Embark Nano Inc. ("Nano", formerly, Axiomm Technologies Ltd.) in Q3 of 2020, Embark is preparing to launch the next generation of Cannabis 2.0 products. The acquired portfolio of products and formulations support the mass production and distribution of advanced 2.0 products including cannabis-infused beverages, topicals, edibles and water-soluble powders. For more information, please visit www.embarknano.com.

It is Embark's mandate to pursue best-in-class production processes resulting in premium quality commercial and consumer extraction products. Embark Health Inc. is dedicated to unleashing the full potential of the cannabis plant through scientific approaches to extraction and the production of quality products to enhance everyday life. For more information, please visit www.embarkhealthinc.com.

Investor Relations Contact:


This news release contains "forward-looking information" within the meaning of applicable securities laws including statements regarding the ability to leverage its existing Cannabis 2.0 products for the Canadian market, access to future markets, Embark's ability to increase production and offer new products and services following receipt of applicable licences, the continued business-to-business activities of Embark, and the effects of the aforementioned activities on the operational and financial condition of Embark. Although Embark believes in light of the estimates by management, current conditions and expected future developments and other factors, that the expectations reflected in this forward-looking information are reasonable, undue reliance should not be placed on them. Accordingly, Embark can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements depending on, among other things, changes in economic conditions or financial markets; regulatory delays; increases in costs; litigation; legislative, environmental and other judicial, regulatory, political and competitive developments; and technological or operational difficulties. This list is not exhaustive of the factors that may affect our forward-looking information. The statements in this press release are made as of the date of this release. The Company assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward-looking statements unless and until required by securities laws applicable to the Company.


To view the source version of this press release, please visit https://www.newsfilecorp.com/release/80809